A sensor that performs well in concept may fail to meet expectations in real-world conditions. Without a robust, data-driven testing strategy, teams risk costly redesigns, delayed trials, and unexpected performance issues. Yet, testing often doesn’t get the attention it deserves in early development, leading to avoidable setbacks.
A well-designed lab test system does more than validate performance - it accelerates decision-making, guides sensor optimisation, and ensures devices are truly ready for in-vivo trials.
As part of our work with CGM developers, TTP’s Biosensing team helped develop an automated CGM testing platform for high-throughput testing, automated data capture, and flexible customisation - helping our clients bring innovative CGM solutions to market faster.
TTP’s automated CGM testing platform has been designed for high-throughput testing, automated data capture, and flexible customisation, helping our clients bring innovative continuous glucose monitoring solutions to market faster.
Download the white paper below
